University of Southern California

Research

Current Master Agreements

USC Clinical Trials Office
July 2014

Executed/Negotiated Master Agreements:

Abbott Vascular
Amgen (New)
Astellas (New)
Bayer
BMS (Master Confidentiality Agreement) (New)
Celgene Corporation (New)
Clinipace (Master Confidentiality Agreement) (New)
Clovis Oncology (New)
Criterium Inc. for two oncology consortiums. (New)
EMD Serono, Inc.
EnVivo Phaemaceuticals (New)
GlaxoSmithKline
Medtronic (New)
Novartis (Industry-initiated CTA)
Sanofi-Aventis
St. Jude Medical, Inc.
Toshiba (New)
UCB Pharmaceuticals (New)